| Serial Number | 98677791 |
| Word Mark | DURASERT E |
| Filing Date | Thursday, August 1, 2024 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, August 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Injectable sustained drug delivery systems consisting of a bioerodible matrix for delivering pharmaceuticals via injection into the posterior segment of the eye |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 1, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EyePoint Pharmaceuticals US, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Event Date | Event Description |
| Thursday, August 1, 2024 | NEW APPLICATION ENTERED |
| Thursday, January 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 7, 2025 | ASSIGNED TO EXAMINER |
| Saturday, February 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 6, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, May 6, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, July 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 25, 2025 | SUSPENSION LETTER WRITTEN |
| Monday, August 25, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, August 25, 2025 | LETTER OF SUSPENSION E-MAILED |
| Monday, July 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 8, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, February 8, 2025 | NON-FINAL ACTION E-MAILED |